Table 1 Patient demographics and baseline characteristics (n = 83)
Patient characteristics | N | % |
|---|---|---|
Median age (range) | 68 | (31–93) |
Sex | ||
 - male | 47 | 57 |
 - female | 36 | 43 |
ECOG | ||
 - 0 | 49 | 59 |
 - 1 | 24 | 29 |
 - 2 | 10 | 12 |
Stage | ||
 - IV | 62 | 75 |
 - III inoperable | 21 | 25 |
Adjuvant chemotherapy | 8 | 9.6 |
Stage III | n = 21 | 100% |
Chemoradiation for locally advanced disease | 7 | 33.3 |
Stage IV | n = 62 | 100% |
Metastatic sites at start of first palliative CHT | ||
 - Liver | 40 | 64.5 |
 - Lung | 15 | 24.2 |
 - Peritoneum | 14 | 22.6 |
 - Bone | 3 | 4.8 |
 - Other | 4 | 6.5 |
Number of metastatic sites | ||
 - 1 | 50 | 80.6 |
 - ≥  2 | 12 | 19.4 |
CA 19.9 (U/l) | ||
 - Median (range) | 1363 | (0–328,209) |
 - ≤  37 | 14 | 16.9 |
 - ≥  37 | 69 | 83.1 |